Terminal
Stocks
Spotlight
News

Stocks
Healthcare
NASDAQ
FBIOP

Market Cap: $148.71M

FI

Fortress Biotech, Inc.

FBIOP

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Cashu Markets Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin64.51%

EBITDA Margin2.24%

EBIT Margin2.16%

Pre-tax Margin2.01%

Net Profit Margin1.93%

Earnings Yield1.21%

Valuation Multiples

Price / Book0.65

Price / Sales1.68

Price / Earnings0.87

PEG0.00

Forward PEG-0.01

EV / Sales-1.38

EV / EBITDA-0.62

EV / Operating Cash Flow-0.58

EV / Free Cash Flow-0.58

Price / Free Cash Flow0.70

Price / Operating Cash Flow0.67

Cash Flow & Capital

Free Cash Flow / Share$5

Operating Cash Flow / Share$5

Free Cash Flow Yield1.42%

Capex / Revenue0.00%

Capex / Operating Cash Flow0.00%

Capex / Depreciation0.00

Stock Compensation / Revenue33.93%

Dividend Payout Ratio0.39%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio2.86

Quick Ratio2.77

Cash Ratio2.47

Debt / Assets0.15

Debt / Capital0.25

Debt / Equity0.33

Long-Term Debt / Capital0.19

Debt / Market Cap35.49%

Net Debt / EBITDA-1.37

Solvency Ratio0.86

Financial Leverage2.20

Efficiency & Working Capital

Asset Turnover0.19

Fixed Asset Turnover4.64

Inventory Turnover2.53

Receivables Turnover2.59

Payables Turnover1.66

Days Sales Outstanding140.72

Days Inventory Outstanding144.46

Days Payables Outstanding219.81

Operating Cycle285.18

Cash Conversion Cycle65.37

Working Capital Turnover0.50

Returns & Quality

Return on Equity1.64%

Return on Assets35.80%

Return on Invested Capital-20.91%

ROCE-22.02%

Return on Tangible Assets38.67%

Operating Return on Assets-20.58%

Income Quality1.54

Tax Burden0.96

Interest Burden0.93

Balance Sheet & Intrinsic Metrics

Enterprise Value$-91.26M

Invested Capital$232.81M

Working Capital$192.09M

Tangible Asset Value$175.9M

Net Current Asset Value$140.98M

Graham Number$21.65

Graham Net-Net$3.97

Book Value / Share$6.42

Tangible Book Value / Share$5.58

Cash / Share$8.11

Financial Health Scores

Piotroski Score4

Altman Z-Score-1.15

Revenue$66.03M

EBIT$-11.67M

Market Cap$148.71M

Working Capital$192.09M

Retained Earnings$-623.68M

Total Assets$356.87M

Total Liabilities$154.5M